Bio-analytical method based on MALDI-MS analysis for the quantification of CIGB-300 anti-tumor peptide in human plasma-Reference-Cited by-同舟云学术

Bio-analytical method based on MALDI-MS analysis for the quantification of CIGB-300 anti-tumor peptide in human plasma

Published:2015-02 Issue: Volume:105 Page:107-114
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Cabrales-Rico Ania,de la Torre Beatriz G.,Garay Hilda E.,Machado Yoan J.,Gómez Jose A.,Audain Enrique,Morales Orlando,Besada Vladimir,Marcelo Jose Luis,Reyes Vilcy,Perera Yasser,Perea Silvio E.,Reyes Osvaldo,González Luis Javier

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference31 articles.

1. Anti-tumor effect of a novel pro-apoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2);Perea;Cancer Res.,2004

2. CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo;Perea;Mol. Cell Biochem.,2008

3. Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice;Perera;Int. J. Cancer,2008

4. Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity,;Perera;Mol. Cancer Ther.,2009

5. Sensitivity of tumor cells towards CIGB-300 anticancer peptide relies on its nucleolar localization;Perera;J. Peptide Sci.,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability in human serum and plasma of the HIV peptide drug candidate CIGB‐210 and improved variants;Biotechnology and Applied Biochemistry;2024-09

2. Analytical Performance Evaluation of New DESI Enhancements for Targeted Drug Quantification in Tissue Sections;Pharmaceuticals;2022-06-01

3. Important Requirements for the Selection of Internal Standards during the Development of Desorption/Ionization Assays for Drug Quantification in Biological Matrices—A Practical Example;Molecules;2022-01-21

4. Desorption/Ionization-MS Methods for Drug Quantification in Biological Matrices and Their Validation Following Regulatory Guidance;Analytical Chemistry;2021-04-29

5. Rapid MALDI-MS Assays for Drug Quantification in Biological Matrices: Lessons Learned, New Developments, and Future Perspectives;Molecules;2021-02-26